| Fermenta Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506414 |
NSE Symbol : - |
P/E(TTM) : 8.31 |
|
ISIN Demat : INE225B01021 |
Div & Yield% : 0.92 |
EPS(TTM) : 32.37 |
|
Book Value(₹) : 136.83 |
Market Cap(₹Cr) : 791.69 |
Face Value(₹) : 5.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 107.12 | 119.02 | 122.04 | 146.25 | 89.54 | 72.70 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 107.12 | 119.02 | 122.04 | 146.25 | 89.54 | 72.70 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.53 | 8.84 | 3.88 | 2.22 | 2.95 | 2.63 |
| Total Income | 112.64 | 127.86 | 125.92 | 148.47 | 92.49 | 75.33 |
| Total Expenditure | 84.15 | 96.49 | 89.36 | 96.12 | 74.05 | 70.89 |
| PBIDT | 28.49 | 31.37 | 36.56 | 52.36 | 18.44 | 4.44 |
| Interest | 2.59 | 3.11 | 2.99 | 4.09 | 3.69 | 3.42 |
| PBDT | 25.91 | 28.27 | 33.57 | 48.26 | 14.75 | 1.01 |
| Depreciation | 5.13 | 5.55 | 5.60 | 5.82 | 5.89 | 5.86 |
| Tax | 3.72 | 4.00 | 4.98 | 7.45 | 0.70 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.34 | 2.48 | -6.32 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 14.72 | 16.23 | 29.31 | 35.00 | 8.16 | -4.85 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 14.72 | 16.23 | 29.31 | 35.00 | 8.16 | -4.85 |
| EPS (Unit Curr.) | 5.05 | 5.57 | 10.05 | 12.05 | 2.81 | -1.68 |
| EPS (Adj) (Unit Curr.) | 5.05 | 5.57 | 10.05 | 12.05 | 2.81 | -1.68 |
| Calculated EPS (Unit Curr.) | 5.06 | 5.57 | 10.05 | 12.00 | 2.81 | -1.68 |
| Calculated EPS (Adj) (Unit Curr.) | 5.06 | 5.57 | 10.05 | 12.00 | 2.81 | -1.68 |
| Calculated EPS (Ann.) (Unit Curr.) | 20.23 | 22.26 | 40.20 | 48.02 | 11.25 | -6.71 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 20.23 | 22.26 | 40.20 | 48.02 | 11.25 | -6.71 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 14.55 | 14.58 | 14.58 | 14.58 | 14.50 | 14.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 26.60 | 26.36 | 29.96 | 35.80 | 20.59 | 6.11 |
| PBDTM(%) | 24.19 | 23.75 | 27.51 | 33.00 | 16.47 | 1.39 |
| PATM(%) | 13.74 | 13.64 | 24.02 | 23.93 | 9.11 | -6.67 |